Last week analyst meeting came out in a slight negative tone considering the weak sales performance outlook for 3Q21. However, we maintain our BUY rating given the narrow impact to our 2021 earnings
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.